MERKEL CELL CARCINOMA

Clinical trials for MERKEL CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new MERKEL CELL CARCINOMA trials appear

Sign up with your email to follow new studies for MERKEL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 16 Not yet recruiting 1 Not yet finished but already full! 16 Completed 1 Terminated 7

New hope for hard-to-treat merkel cell cancer: drug combo aims to shrink tumors

Disease control Not yet recruiting

This study tests whether combining two drugs—ASTX727 (a pill) and retifanlimab (given through a vein)—can shrink tumors and slow cancer growth in people with advanced Merkel cell cancer that no longer responds to standard immunotherapy. About 31 adults will receive the treatment …

Matched conditions: MERKEL CELL CARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control

Last updated May 11, 2026 20:40 UTC

MERKEL CELL CARCINOMA

Get alerted when new MERKEL CELL CARCINOMA trials appear

New hope for hard-to-treat merkel cell cancer: drug combo aims to shrink tumors